Personalized mRNA vaccine shows promise in preventing melanoma recurrence when combined with immunotherapy
By
Allison Aubrey
Kettled twice. Extra chewy, extra trustworthy.
Summary
An 80-year-old melanoma patient, Connie Franciosi, participated in a clinical trial testing an mRNA cancer vaccine (mRNA-4157/V940) combined with the immunotherapy drug Keytruda. The study found the personalized mRNA vaccine is highly effective at preventing melanoma recurrence in high-risk patients. The vaccine is custom-built for each patient based on their tumor's genetic mutations, training the immune system to recognize and attack cancer cells. Results showed a 65% reduction in the risk of death or recurrence compared to Keytruda alone. The technology represents a promising new frontier for mRNA beyond COVID-19 vaccines, with potential applications for other cancers.
Key quotes
· 3 pulledIt was considered a late diagnosis.
The vaccine is designed to train the immune system to recognize the patient's specific cancer cells as foreign and attack them.
This is a major breakthrough in the fight against melanoma and demonstrates the potential of mRNA technology beyond infectious diseases.
You might also wanna read
Personalized mRNA Cancer Vaccine Shows 49% Risk Reduction at 5-Year Follow-up
Moderna and Merck report promising 5-year follow-up results for their personalized mRNA cancer vaccine combined with Keytruda immunotherapy.
arstechnica.com·4mo ago
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·10mo ago
Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59
This cohort study analyzes data from over 28 million French adults aged 18-59 to examine the association between mRNA COVID-19 vaccination a
jamanetwork.com·6mo ago
Long-term HPV vaccine effectiveness study shows stable protection against targeted virus types in Danish women vaccinated as girls
This study examines the long-term effectiveness of HPV vaccination in Danish women who received the 4-valent HPV vaccine as girls in 2008. T
eurosurveillance.org·5mo ago